BCS Stock Analysis: Barclays | NYSE
Banks - Diversified | NYSE, USA | Market Cap: 87.832m USD | 12M Return: 43% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 149M
EPS Trend: 87.5%
Qual. Beats: 0
Rev. Trend: 75.9%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Barclays PLC (NYSE: BCS) is a London-headquartered global financial services company founded in 1690, making it one of the oldest banking institutions in the UK. It operates through five main segments: Barclays UK, Barclays UK Corporate Bank, Barclays Private Bank and Wealth Management, Barclays Investment Bank, and Barclays US Consumer Bank. The company offers a broad range of services including retail banking (current accounts, savings, mortgages, credit cards, and loans), wholesale and investment banking, wealth and investment management, and securities dealing. As a diversified bank, Barclays generates revenue across both consumer-facing and corporate/institutional lines, and trades on the NYSE as an American Depositary Receipt (ADR), allowing US investors to hold shares in the UK-domiciled company.
- UK net interest margins compress as BoE cuts rates
- Investment Banking revenue rises on FICC and advisory recovery
- US credit card losses climb as borrower delinquencies worsen
| Net Income: 7.88b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA -0.81 > 1.0 |
| NWC/Revenue: -546.0% < 20% (prev -1.48k%; Δ 936.3% < -1%) |
| CFO/TA -0.00 > 3% & CFO -6.21b > Net Income 7.88b |
| Net Debt (-318b) to EBITDA (11.8b): -26.95 < 3 |
| Current Ratio: 0.68 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.43b) vs 12m ago -3.41% < -2% |
| Gross Margin: 45.58% > 18% (prev 92.11%; Δ -46.53% > 0.5%) |
| Asset Turnover: 2.39% > 50% (prev 1.72%; Δ 0.67% > 0%) |
| Interest Coverage Ratio: 0.46 > 6 (EBIT TTM 10.0b / Interest Expense TTM 21.7b) |
| A: -0.13 (Total Current Assets 456b - Total Current Liabilities 674b) / Total Assets 1730b |
| B: 0.03 (Retained Earnings 60.4b / Total Assets 1730b) |
| C: 0.01 (EBIT TTM 10.0b / Avg Total Assets 1665b) |
| D: 0.05 (Book Value of Equity 79.4b / Total Liabilities 1651b) |
| Altman-Z'' = -0.62 = B |
As of August 01, 2026, the stock is trading at USD 27.50 with a total of 4,949,211 shares traded. Over the past week, the price has changed by -1.47%, over one month by +2.38%, over three months by +17.47% and over the past year by +43.00%.
Current recommended Stop Loss: 26.10 (which is 5.1% or 1.6 ATR below the current price).
Barclays has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy BCS.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 29.2 | 6.1% |
Market Cap GBP = 65.3b (87.8b USD * 0.7431 USD.GBP)
P/E Trailing = 10.504
P/E Forward = 9.8328
P/S = 3.1211
P/B = 0.8586
P/EG = 1.6394
Revenue TTM = 39.9b GBP
EBIT TTM = 10.0b GBP
EBITDA TTM = 11.8b GBP
Long Term Debt = 76.7b GBP (from longTermDebt, last fiscal year)
Short Term Debt = 73.1b GBP (from shortTermDebt, last fiscal year)
Debt = 138b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -318b GBP (calculated: Debt 138b - CCE 456b)
Enterprise Value = 65.3b GBP (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 0.46 (Ebit TTM 10.0b / Interest Expense TTM 21.7b)
EV/FCF = -8.09x (Enterprise Value 65.3b / FCF TTM -8.07b)
FCF Yield = -12.36% (FCF TTM -8.07b / Enterprise Value 65.3b)
FCF Margin = -20.25% (FCF TTM -8.07b / Revenue TTM 39.9b)
Net Margin = 19.76% (Net Income TTM 7.88b / Revenue TTM 39.9b)
Gross Margin = 45.58% ((Revenue TTM 39.9b - Cost of Revenue TTM 21.7b) / Revenue TTM)
Gross Margin QoQ = none% (prev 89.68%)
Tobins Q-Ratio = 0.04 (Enterprise Value 65.3b / Total Assets 1730b)
Interest Expense / Debt = 15.72% (Interest Expense 21.7b / Debt 138b)
Taxrate = 21.22% (2.13b / 10.0b)
NOPAT = 7.91b (EBIT 10.0b * (1 - 21.22%))
Current Ratio = 0.68 (Total Current Assets 456b / Total Current Liabilities 674b)
Debt / Equity = 1.74 (Debt 138b / totalStockholderEquity, last quarter 79.4b)
Debt / EBITDA = -26.95 (Net Debt -318b / EBITDA 11.8b)
Debt / FCF = 39.41 (negative FCF - burning cash) (Net Debt -318b / FCF TTM -8.07b)
Total Stockholder Equity = 77.6b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.47% (Net Income 7.88b / Total Assets 1730b)
RoE = 10.16% (Net Income TTM 7.88b / Total Stockholder Equity 77.6b)
RoCE = 6.51% (EBIT 10.0b / Capital Employed (Equity 77.6b + L.T.Debt 76.7b))
RoIC = 0.70% (NOPAT 7.91b / Invested Capital 1128b)
WACC = 11.66% (E(65.3b)/V(203b) * Re(10.11%) + D(138b)/V(203b) * Rd(15.72%) * (1-Tc(0.21)))
Discount Rate = 10.11% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -87.05 | Cagr: -3.82%
[DCF] Fair Price = unknown (Cash Flow -8.07b)
EPS Correlation: 87.46 | EPS CAGR: 17.85% | SUE: 0.21 | # QB: 0
Revenue Correlation: 75.94 | Revenue CAGR: 11.43% | SUE: 0.86 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.74 | Chg30d=+2.73% | Revisions=+25% | Analysts=1
EPS current Year (2026-12-31): EPS=2.82 | Chg30d=-0.17% | Revisions=+0% | GrowthEPS=+17.3% | GrowthRev=+6.8%
EPS next Year (2027-12-31): EPS=3.40 | Chg30d=+0.36% | Revisions=+0% | GrowthEPS=+20.3% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: +12% (up=3, down=2)